UBS Identifies 8 Midcap Stocks with Up to 84% Upside Potential

• UBS highlights eight midcap stocks with significant upside potential, despite the midcap index's one-year forward PE correcting by 10% in 2025.
• Valuations for midcaps still trade at a premium to their five-year average and the Nifty, with domestic fund managers shifting towards large caps.
• Key picks include Shaily Engineering (beneficiary of generic GLP-1 drugs), Max Healthcare (margin improvement from new facilities), and Indian Hotels (robust demand).
• Other recommended stocks are Shyam Metalics (rising commodity prices), Fortis Healthcare (margin trajectory, expansions), Astral (market share gains, PVC pricing), APL Apollo Tubes (EBITDA per tonne improvement), and Delhivery (efficiency gains, pricing).
• UBS provides target prices, with Shaily Engineering Plastics having the highest potential upside at 84% to ₹4,000.

Why It Matters: UBS pinpoints eight midcap stocks offering substantial growth, with Shaily Engineering leading at 84% upside.